[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ron Reece [@Mujhunter](/creator/twitter/Mujhunter) on x 3519 followers Created: 2025-07-26 17:07:35 UTC Better question.. Why is MAHA ignoring Self-Amplifying mRNA, AND the strong likelihood that EARLY treatment ZINC + Ionophores ie: HCQ, EGCG, Quercetin.. etc) would neutralize their function? The implicit logic would then suggest that such EARLY treatments would ALSO neutralize the actual RNA viruses.. also likely Broad Spectrum in their effectiveness against all RNA viruses. Early treatment would mean we don't really have a need for risky, experimental (EUA) mass vaccinations, wouldn't it? For some, it will take a bit of understanding about the role of RdRP/"Replicons". We should ask Dr. Ralph Baric (under oath) about this. He is, after all, a Gain of Function EXPERT, as well as a member of the National Academy of Sciences. His non-profit, READDI, seems to be working on exactly just such a Broad Spectrum Antiviral therapeutic protocol..  XXX engagements  **Related Topics** [spectrum](/topic/spectrum) [zinc](/topic/zinc) [maha](/topic/maha) [ron](/topic/ron) [Post Link](https://x.com/Mujhunter/status/1949154643407413675)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ron Reece @Mujhunter on x 3519 followers
Created: 2025-07-26 17:07:35 UTC
Better question.. Why is MAHA ignoring Self-Amplifying mRNA, AND the strong likelihood that EARLY treatment ZINC + Ionophores ie: HCQ, EGCG, Quercetin.. etc) would neutralize their function?
The implicit logic would then suggest that such EARLY treatments would ALSO neutralize the actual RNA viruses.. also likely Broad Spectrum in their effectiveness against all RNA viruses.
Early treatment would mean we don't really have a need for risky, experimental (EUA) mass vaccinations, wouldn't it?
For some, it will take a bit of understanding about the role of RdRP/"Replicons".
We should ask Dr. Ralph Baric (under oath) about this. He is, after all, a Gain of Function EXPERT, as well as a member of the National Academy of Sciences.
His non-profit, READDI, seems to be working on exactly just such a Broad Spectrum Antiviral therapeutic protocol..
XXX engagements
/post/tweet::1949154643407413675